STOCK TITAN

Cardlytics (CDLX) Stock News

CDLX Nasdaq

Welcome to our dedicated page for Cardlytics news (Ticker: CDLX), a resource for investors and traders seeking the latest updates and insights on Cardlytics stock.

Cardlytics reports as a Nasdaq-listed commerce media platform that connects advertisers with consumers through publishers’ digital channels and a card-linked offer network. Company updates commonly cover revenue, billings, consumer incentives, partner-share costs, adjusted contribution, Adjusted EBITDA, and guidance tied to advertiser demand and publisher relationships.

Recurring announcements also address governance and equity compensation under its inducement plan, capital-structure matters, and strategic portfolio actions. Recent company history includes the completed divestiture of Bridg, the identity resolution and shopper intelligence platform that had used point-of-sale data for analytics, loyalty marketing, and measurement.

Rhea-AI Summary

The Schall Law Firm, a national shareholder rights litigation firm, is investigating Cardlytics, Inc. (NASDAQ:CDLX) for potential securities law violations. The investigation centers on whether Cardlytics issued false or misleading statements or failed to disclose important information to investors. The company's Q2 2024 financial results, released on August 7, 2024, significantly missed projections made just three months earlier. Cardlytics attributed the shortfall to "fast-paced changes to our technology platform," but when questioned by analysts, management admitted that these technology issues had been known for "a quarter or two." The firm encourages affected shareholders to participate in the investigation and offers free consultations to discuss investor rights.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.06%
Tags
none
-
Rhea-AI Summary

Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks' digital channels, has announced the granting of 49,900 restricted stock units to seven newly hired employees. The grants were approved by the Compensation Committee of Cardlytics' Board of Directors on August 19, 2024, as material inducements to employment under Nasdaq Listing Rule 5635(c)(4).

The restricted stock units were granted under the Cardlytics, Inc. 2022 Inducement Plan. For all recipients, 50% of the units will vest on the first anniversary of the grant date, with the remaining 50% vesting quarterly over the subsequent 12 months, subject to continuous service with Cardlytics.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.24%
Tags
none
-
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX) reported Q2 2024 financial results, showing mixed performance. Revenue decreased 9% year-over-year to $69.6 million, while billings increased 1% to $110.4 million. The company faced challenges with slower-than-anticipated billings growth and higher consumer incentives. Net loss improved to $(4.3) million from $(23.5) million in Q2 2023. Adjusted EBITDA loss narrowed to $(2.3) million from $(4.1) million last year.

Key metrics showed Cardlytics MAUs increased 3% to 165.5 million, but ARPU declined to $0.42 from $0.48 in Q2 2023. The company remains confident in its long-term potential despite near-term challenges. For Q3 2024, Cardlytics expects billings between $100-$106 million and revenue between $56-$63 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-57.1%
Tags
News
Rhea-AI Summary

Cardlytics, Inc. (NASDAQ: CDLX) has announced a significant leadership change. Amit Gupta, currently Chief Operating Officer and General Manager of Bridg, will become the new Chief Executive Officer effective August 16, 2024. He will also join the company's Board of Directors. Gupta replaces Karim Temsamani, who is stepping down to pursue another opportunity.

Gupta, who joined Cardlytics in January 2023, has been instrumental in setting the course for the company's transformation and long-term growth plans. With his extensive product and technology experience, he is expected to lead Cardlytics in its next growth phase, focusing on modernizing the tech platform and executing the revenue diversification strategy with Bridg.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-57.1%
Tags
management
-
Rhea-AI Summary

Cardlytics (NASDAQ: CDLX), an advertising platform in banks' digital channels, has announced the timing of its second quarter 2024 earnings release. The financial results for the quarter ended June 30, 2024, will be released on August 7, 2024, after market close. The company will host a conference call to discuss the results at 5:00 PM (ET) / 2:00 PM (PT) on the same day.

Investors are invited to join a live audio webcast or dial in to participate in the earnings call. A replay of the call will be available on the Cardlytics Investor Relations website for those unable to attend the live event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
-
Rhea-AI Summary

Cardlytics' Bridg division announced that Giant Eagle's Leap Media Group has joined the Rippl data and media network. This collaboration provides advertisers access to over 70 million shopper profiles, enhancing data-driven advertising strategies. Rippl's cookieless identity resolution technology and SKU-level purchase data enable tailored campaigns and consistent performance measurement across retailers. Giant Eagle's participation aims to elevate shopper engagement, drive growth, and ensure data privacy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.93%
Tags
none
Rhea-AI Summary

Cardlytics, Inc. announced their first quarter 2024 financial results, showcasing a 5% increase in revenue, 10% growth in billings, and a 20% rise in adjusted contribution year-over-year. Despite a net loss, the company saw positive adjusted EBITDA and improvement in balance sheet, with strong momentum in international business.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-36.51%
Tags
-
Rhea-AI Summary

Cardlytics, Inc. announced the grant of 38,500 restricted stock units to five new employees as inducements for employment. The grants were made under the 2022 Inducement Plan in accordance with Nasdaq Listing Rule 5635(c)(4). The restricted stock units have different vesting schedules, with some vesting in full after one year and others vesting partially over a period of 12 months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.51%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.98%
Tags
management

FAQ

What is the current stock price of Cardlytics (CDLX)?

The current stock price of Cardlytics (CDLX) is $0.651 as of May 11, 2026.

What is the market cap of Cardlytics (CDLX)?

The market cap of Cardlytics (CDLX) is approximately 36.9M.